Identity Management Challenges In Pharma & Biotech SaaS Platforms (And How To Solve Them)
Security Boulevard, Friday, January 16th, 2026
Pharmaceutical and biotech organizations are rapidly adopting SaaS platforms to support drug discovery, clinical development, manufacturing, quality management, and commercialization.
Cloud-based tools enable faster innovation, real-time collaboration, and global scalability-but they also introduce significant identity and access management (IAM) challenges. With sensitive intellectual property, regulated data, and a wide ecosystem of internal and external users, identity management has become a critical foundation of digital trust.
In this environment, fragmented or outdated IAM approaches can lead to compliance gaps, security incidents, and operational inefficiencies. To fully realize the benefits of SaaS while minimizing risk, life sciences organizations must rethink how identity is managed across modern platforms.